US Broker Ratings

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: A Biotech Contender with 17.99% Upside Potential

For investors with a keen eye on the healthcare sector, Enliven Therapeutics, Inc. (NASDAQ: ELVN) presents a compelling opportunity. This clinical-stage biopharmaceutical company, with a market cap of $4.42 billion,..

Avanos Medical, Inc. (AVNS) Stock Analysis: Exploring Growth Prospects in the Medical Devices Sector

Avanos Medical, Inc. (NYSE: AVNS) stands as a notable player in the healthcare sector, specifically within the medical devices industry. Headquartered in Alpharetta, Georgia, Avanos has carved out a niche..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating Challenges Amid Biotechnology Innovations

Ginkgo Bioworks Holdings, Inc. (NASDAQ: DNA) is a prominent player in the biotechnology industry, renowned for its pioneering work in cell engineering and biosecurity. As investors consider the potential opportunities..

Castle Biosciences, Inc. (CSTL) Stock Analysis: Exploring a 44% Upside Potential in the Diagnostics Sector

For individual investors seeking opportunities in the healthcare sector, Castle Biosciences, Inc. (NASDAQ: CSTL) presents a compelling case. As a key player in the diagnostics and research industry, the company..

Talkspace, Inc. (TALK) Stock Analysis: Exploring the 18% Potential Upside in Virtual Behavioral Healthcare

Investors eyeing the burgeoning field of telehealth might find Talkspace, Inc. (NASDAQ: TALK) an intriguing prospect. With its unique position in the virtual behavioral healthcare industry, Talkspace offers a platform..

AbCellera Biologics Inc. (ABCL) Stock Analysis: A 60.80% Potential Upside in the Biotech Sector

AbCellera Biologics Inc. (NASDAQ: ABCL) is making waves in the biotechnology sector with its innovative approach to antibody-based medicines. As a Canadian company with a market cap of $1.99 billion,..

InnovAge Holding Corp. (INNV)

⚠️ No article content returned.

..

Akebia Therapeutics, Inc. (AKBA) Investor Outlook: Analyzing a 340% Potential Upside Amid Healthcare Innovation

Akebia Therapeutics, Inc. (NASDAQ: AKBA) finds itself at an intriguing juncture for investors, particularly those with an eye for high-reward opportunities in the biopharmaceutical sector. With a market capitalization currently..

Tectonic Therapeutic, Inc. (TECX) Investor Outlook: Exploring a 159.58% Potential Upside

Tectonic Therapeutic, Inc. (NASDAQ: TECX), a burgeoning player in the biotechnology sector, is rapidly gaining traction among investors with a compelling proposition: a potential upside of 159.58%. This Massachusetts-based company..

Beta Bionics, Inc. (BBNX) Stock Analysis: 42% Potential Upside Amidst Innovative Diabetes Solutions

Investors with an eye on the healthcare sector, particularly within the medical devices industry, might find Beta Bionics, Inc. (NASDAQ: BBNX) an intriguing opportunity. With a market capitalization of $634.8..

Embecta Corp. (EMBC) Stock Analysis: Exploring a High Dividend Yield with a 14.29% Upside Potential

Embecta Corp. (NASDAQ: EMBC) is a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. Based in Parsippany, New Jersey, Embecta has carved a niche..

Delcath Systems, Inc. (DCTH) Stock Analysis: A Promising 52.24% Potential Upside for Healthcare Investors

Delcath Systems, Inc. (NASDAQ: DCTH) presents a captivating opportunity for investors focused on the healthcare sector, particularly in the niche of medical devices. With a market capitalization of $534.05 million,..

Kura Oncology, Inc. (KURA) Stock Analysis: Exploring a 235.85% Potential Upside in the Biotechnology Sector

For investors with a keen eye on the biotechnology sector, Kura Oncology, Inc. (KURA) presents a compelling opportunity. Positioned as a clinical-stage biopharmaceutical company, Kura Oncology focuses on the development..

Bicara Therapeutics Inc. (BCAX) Investor Outlook: Tapping into a 14% Upside with Innovative Biotech Solutions

Bicara Therapeutics Inc. (NASDAQ: BCAX), the Boston-based clinical-stage biopharmaceutical company, is making waves in the biotechnology industry with its promising approach to cancer treatment. Specializing in bifunctional therapies for solid..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Strong Revenue Growth and High ROE Offer Intriguing Investment Prospects

Theravance Biopharma, Inc. (NASDAQ: TBPH), a prominent player in the biotechnology sector, is captivating investor attention with its robust revenue growth and an impressive return on equity. Known for its..

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a Potential 509% Upside in Biotech

Anavex Life Sciences Corp. (NASDAQ: AVXL) is catching the attention of investors with its intriguing potential upside in the biotechnology sector. With a market capitalization of approximately $303.96 million, this..

Zenas BioPharma, Inc. (ZBIO): Investor Outlook on a Potential 35% Upside

Zenas BioPharma, Inc. (NASDAQ: ZBIO), a dynamic player in the biotechnology sector, has been capturing investor attention with its promising portfolio of immunology-based therapies. With a market capitalization of $2.03..

Bioventus Inc. (BVS) Stock Analysis: Healthcare Innovator with 5.87% Upside Potential

Bioventus Inc. (BVS), a key player in the healthcare sector, is making notable strides in the medical device industry with a focus on innovative pain relief and musculoskeletal therapies. Based..

Valneva SE (VALN) Stock Analysis: Can Its 135% Upside Potential Attract Investors?

Valneva SE (NASDAQ: VALN), a prominent player in the biotechnology sector with a focus on developing vaccines for infectious diseases, stands at a crucial juncture for potential investors. With its..

Zymeworks Inc. (ZYME): Analyst Consensus and Potential 72% Upside Make This Biotech Stock Worth Watching

Zymeworks Inc. (NASDAQ: ZYME), a prominent player in the biotechnology sector, is capturing investor attention with its cutting-edge developments in biotherapeutics aimed at treating cancer, inflammation, and autoimmune diseases. With..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds